Pharvaris
Manfred Rettenbacher is currently the Executive Director of Clinical Development & Medical Affairs at Pharvaris. Previously, Manfred held various leadership roles in clinical development and medical affairs at companies such as LAHSA, Finox Biotech AG, Sanofi Pasteur MSD, Cytos Biotechnology AG, and Biomit Inc. Manfred has a Doctor of Medicine degree from the University of Bern and an Executive Master of Business Administration in Innovation Management from Bern University of Applied Sciences, Engineering and Information Technology. Additionally, Manfred holds a CAS Pharmaceutical Medicine degree from Biozentrum, University of Basel.
This person is not in any offices
Pharvaris
2 followers
Pharvaris is a preclinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (HAE) and other B2 receptor-mediated indications. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.